查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1932010

自锁倒刺缝线市场：按成分、材料、最终用户、分销管道和应用划分，全球预测（2026-2032年）

Self-Locking Barbed Sutures Market by Configuration, Material, End User, Distribution Channel, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年自锁倒刺缝合线市值为4.5898亿美元，预计2026年将成长至5.0583亿美元，年复合成长率为10.52%，到2032年将达到9.2459亿美元。

主要市场统计数据
基准年 2025 4.5898亿美元
预计年份：2026年 5.0583亿美元
预测年份：2032年 9.2459亿美元
复合年增长率 (%) 10.52%

本书全面介绍了缝合线设计的进步、临床实践的转变以及材料创新如何重塑外科缝合策略。

随着缝合技术的进步，临床医师不断寻求能够减少打结复杂性、缩短伤口缝合时间的材料和结构，工程化自锁倒刺缝合线在外科领域正迅速普及。这类缝合线的特点是沿线分布一系列倒刺，无需传统打结即可捕获组织并分散张力，从而实现一致的伤口边缘对合，并减少手术步骤。近期研究的进展改进了倒刺形态、缝合线柔软性和表面处理，以增强组织整合、最大限度地减少摩擦阻力并降低发炎反应。

手术缝合产品竞争格局与市场接受度的流程创新；器械工程与价值驱动型采购的协调一致

自锁倒刺缝合线的市场环境正经历着变革性的转变，这种转变受到临床实践、器械工程和医疗保健系统优先事项等多种因素的共同驱动。微创手术的稳定发展推动了对能够在有限手术空间内可靠发挥作用的缝合线的需求。同时，加速术后復健通讯协定的广泛应用促使人们关注能够缩短手术时间和减少术后併发症的缝合技术。除了这些手术因素外，产品层面的创新也推动了对倒刺形态、线材涂层以及针对不同组织类型和治疗时间长度的吸收性能的关注。

评估关税带来的成本压力和供应链重组如何重塑医疗设备供应链的筹资策略和优先事项。

对医疗设备零件征收特定关税正在对整个供应链产生连锁反应，影响采购决策、筹资策略和成本结构，但并未改变临床绩效预期。由于关税推高了进口原材料和成品的到岸成本，製造商面临投入成本增加的困境，这往往促使他们重新评估供应商关係，考虑本地生产能力，并探索能够在保持临床性能的同时提高成本弹性的替代材料。这些供应侧的调整可能会导致短期内前置作业时间週期延长，因为製造商需要重新评估供应商资格并扩大国内产能。

从详细的细分观点，阐明配置选择、材料科学、临床环境、分销管道和手术应用如何决定产品定位和市场接受度。

此细分架构突显了自锁倒刺缝合线市场在产品配置、材料科学决策、终端用户环境、分销策略和外科应用方面的多样性。就配置而言，该市场可区分双向缝线（倒刺方向相反，用于张力平衡）和单向缝线（可实现分阶段组织缝合）。这些配置选择会影响缝线的操作、缝合技术以及对特定手术的适用性。

主要全球市场的区域性市场接受度驱动因素和监管考虑将影响市场准入策略、采购趋势和在地化生产决策。

区域趋势揭示了美洲、欧洲、中东和非洲以及亚太地区不同的应用驱动因素、监管环境和供应链模式，这些因素各自影响着製造商和供应商的战略重点。在美洲，临床医生主导的创新和微创手术的高普及率有利于先进缝合线的设计，而大型医疗系统的集中采购则凸显了已证实疗效和成本效益的重要性。在这种环境下，可靠的临床证据以及与医院效率提升计画的契合度至关重要。

对竞争动态和策略伙伴关係的关键洞察将决定製造商、创新者和合约合作伙伴如何赢得外科医生的青睐和采购合约。

自锁倒刺缝线领域的竞争格局由多家成熟的跨国医疗设备製造商、专业缝线公司、利基创新企业和契约製造合作伙伴共同构成，它们各自为该生态系统带来不同的优势。大型製造商通常利用其广泛的外科产品系列、丰富的监管经验和全球分销网络，大规模推出渐进式创新产品，并提供配套的培训和服务项目，以支持外科医生采用这些产品。专业缝合线製造商则往往凭藉其材料科学专长、独特的倒刺形态以及针对特定外科手术的临床证据而脱颖而出。

加速推广应用与降低商业风险的实际策略行动：证据产生、外科医师协作、供应链韧性以及通路优化整合

业界领导者可以采取多项切实可行的措施，加速自锁倒刺缝线的推广应用，巩固自身市场地位，同时降低供应链和健保报销的风险。首先，应优先进行与高频手术和相关人员相符的、有针对性的证据收集工作。对比研究和真实世界数据若能证明自锁倒刺缝线可以缩短手术时间、改善伤口完整性或降低后续成本，将对临床医师和采购团队极具吸引力。其次，应增加对外科医师培训和推广应用支援计画的投入。透过模拟、指导和数位化学习模组，减少初期推广障碍，并将初步接触转化为持续使用。

采用严谨的混合调查方法，结合临床医师访谈、二手文献回顾和情境分析，检验了采纳驱动因素和供应链因应措施。

本执行摘要的研究结合了对外科领域意见领袖、采购专业人员和分销主管的定性调查，以及对临床文献、监管文件和医疗设备标籤文件的二手分析。结构化访谈和引导式讨论​​收集了第一手见解，例如实际操作偏好、流程考虑和采购决策标准。这些定性资料与二手资讯进行检验，以检验流程采用趋势、监管发展和材料科学创新。

一项综合分析，将临床获益、商业化必要性和供应链韧性联繫起来，以指导先进缝合技术的长期应用前景。

总之，自锁倒刺缝线反映了材料科学、主导需求和供应链考量三者之间的策略性性交汇，这些因素共同影响该产品在外科领域的应用。该类缝合线的吸引力源于其临床优势，例如简化缝合流程和实现一致的组织对合。同时，实证医学证据、外科医生培训计画和稳健的筹资策略日益成为竞争格局的关键因素。随着医疗系统将效率和疗效置于首位，那些展现出手术优势并符合采购优先事项的缝线将更有可能获得持续的临床应用。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 自锁倒刺缝合线市场（按类型划分）

  • 双向
  • 单向

9. 自锁倒刺缝合线市场（依材料分类）

  • 吸收性
    • Poliglecaprone
    • 氧环己酮聚合体
    • 聚乙醇酸
  • 不可吸收
    • 聚对苯二甲酸乙二酯
    • 聚丙烯
    • 防锈的

第十章 自锁倒刺缝合线市场（依终端用户划分）

  • 门诊手术中心
  • 医院
  • 专科诊所

第十一章 自锁倒刺缝合线市场（依通路划分）

  • 离线
  • 在线的

第十二章 自锁倒刺缝合线市场（依应用领域划分）

  • 心胸外科
  • 一般外科
  • 妇科手术
  • 整形外科手术
  • 整形外科
  • 泌尿系统

13. 自锁倒刺缝合线市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 自锁倒刺缝合线市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国自锁倒刺缝合线市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国自锁倒刺缝线市场

第十七章：中国自锁倒刺缝线市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AD Surgical
  • Assut Europe
  • B Braun SE
  • CONMED Corporation
  • Corza Medical
  • DemeTECH Corporation
  • Futura Surgicare Private Limited
  • Genesis Medtech Group
  • Healthium Medtech Ltd
  • Johnson & Johnson Services Inc
  • Katsan Medical Devices
  • Lotus Surgicals Pvt Ltd
  • Medtronic PLC
  • Peters Surgical
  • Samyang Holdings Corporation
  • Smith & Nephew PLC
  • Sutumed Corp
  • Suture Planet
  • Teleflex Incorporated
  • Unisur Lifecare Pvt Ltd
  • Universal Sutures
Product Code: MRR-7B550E008E1D

The Self-Locking Barbed Sutures Market was valued at USD 458.98 million in 2025 and is projected to grow to USD 505.83 million in 2026, with a CAGR of 10.52%, reaching USD 924.59 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 458.98 million
Estimated Year [2026] USD 505.83 million
Forecast Year [2032] USD 924.59 million
CAGR (%) 10.52%

A comprehensive introduction to how advances in suture design, clinical practice shifts, and material innovation are reshaping surgical closure strategies

The evolution of suturing technologies has accelerated the adoption of engineered self-locking barbed sutures across surgical specialties, as clinicians seek materials and configurations that reduce knot-tying complexity and streamline closure times. These devices integrate a sequence of barbs along the filament that engage tissue and distribute tension without conventional knots, enabling consistent wound approximation and reducing procedural steps. Recent advances have refined barb geometry, filament flexibility, and surface treatments to improve tissue integration, minimize drag, and reduce inflammatory response.

In addition to engineering improvements, the clinical landscape is shaped by expanding minimally invasive techniques, greater emphasis on operating room efficiency, and rising demand for reliable closure solutions that support enhanced recovery pathways. Surgeons and procurement teams are evaluating suture options through the lenses of clinical outcomes, handling characteristics, and total procedural cost. As a result, product development is converging on hybrid performance attributes that balance tensile integrity, controlled absorption profiles for certain materials, and compatibility with diverse surgical access methods.

This context frames a competitive environment where material science, regulatory clarity, and surgeon training converge to determine product adoption. Understanding the interplay of these forces is essential for stakeholders seeking to position offerings effectively and to anticipate the operational implications of evolving clinical protocols.

How procedural innovation, device engineering, and value-based procurement are converging to redefine competition and adoption in surgical closure products

The landscape for self-locking barbed sutures is experiencing transformative shifts driven by converging forces in clinical practice, device engineering, and health system priorities. Minimally invasive surgery's steady expansion has elevated demand for sutures that perform reliably in constrained workspaces, while enhanced recovery after surgery protocols have increased scrutiny on closure techniques that can shorten procedure times and reduce postoperative complications. These procedural drivers are complemented by product-level innovations that emphasize barb geometry, filament coatings, and absorption characteristics tailored to tissue types and healing timelines.

Concurrently, supply chain optimization and value-based purchasing models are prompting hospitals and ambulatory centers to assess lifecycle costs alongside clinical benefits. This has led to deeper collaboration between manufacturers and clinicians to demonstrate outcome-linked advantages, support training, and integrate product performance into bundled care pathways. As technological maturity grows, new entrants and established device makers are refining service models around training, product differentiation, and evidence generation to secure surgeon preference.

Taken together, these shifts create a more outcome-driven buying environment in which clinical evidence, operational efficiency, and material performance are the primary axes of competition. Stakeholders that align product design, pricing, and education efforts with these priorities are positioned to capture sustained clinical adoption.

Assessing how tariff-driven cost pressures and supply chain reconfiguration are reshaping sourcing strategies and procurement priorities across the medical device supply chain

The introduction of targeted tariffs on medical device components has rippled through supply chains, affecting sourcing decisions, procurement strategies, and cost structures without altering clinical performance expectations. When tariffs increase the landed cost of imported raw materials or finished devices, manufacturers face elevated input expenses that often prompt reassessment of supplier relationships, consideration of local manufacturing capacity, and exploration of alternative materials that maintain clinical profiles while improving cost resilience. These supply-side adjustments can extend lead times in the near term as manufacturers requalify suppliers or expand domestic capabilities.

On the demand side, healthcare providers responding to constrained budgets may intensify cost-containment efforts, shifting purchasing to products that offer demonstrable reductions in operating room time or improved patient throughput. Procurement teams are likely to renegotiate contracts, emphasize total cost of ownership, and require clearer evidence of clinical value to justify price differentials. In parallel, distributors and direct channels will refine inventory strategies to manage tariff-induced price variability and preserve continuity of supply for high-utilization items.

Overall, tariff-related pressures accelerate strategic responses including nearshoring, vertical integration, and intensified supplier diversification. These adaptations are raising the strategic priority of supply chain transparency and risk mitigation in procurement discussions, and they are prompting manufacturers to present more robust economic value cases alongside clinical data.

Detailed segmentation perspectives that clarify how configuration choices, material science, care settings, channels, and procedural applications determine product positioning and adoption

A nuanced segmentation framework underscores the diversity of product configurations, material science decisions, end-user settings, distribution strategies, and surgical applications that define the self-locking barbed suture landscape. From a configuration standpoint, the market differentiates between bidirectional filaments that feature opposing barb orientations to balance tension and unidirectional designs that support progressive tissue approximation, and these configuration choices influence handling, closure technique, and suitability for specific procedures.

Material selection further refines product positioning, with absorbable options-such as poliglecaprone, polydioxanone, and polyglycolic acid-chosen for scenarios requiring predictable resorption aligned to tissue healing profiles, while nonabsorbable materials like polyethylene terephthalate, polypropylene, and stainless steel are preferred where permanent tensile support is necessary. Each material family presents distinct trade-offs in terms of tensile retention, tissue reaction, and handling properties, which in turn affect surgeon preference and procedural fit.

End-user segmentation spans ambulatory surgical centers, hospitals, and specialty clinics, reflecting differences in case mix, procurement protocols, and volume dynamics. Distribution channels include direct tender relationships, distributor networks, and online channels, each offering different service levels, inventory models, and contracting complexities. Application segmentation covers cardiothoracic, general, gynecological, orthopedic, plastic, and urological surgeries, with nested technique distinctions such as minimally invasive versus open approaches, laparoscopic versus open general and gynecological procedures, arthroscopic versus open orthopedic interventions, cosmetic versus reconstructive plastic operations, and endoscopic versus open urological surgeries. Together, these segmentation axes form the basis for targeted product design, go-to-market strategies, and clinical evidence generation plans.

Regional adoption drivers and regulatory considerations across major global markets that influence access strategies, procurement dynamics, and local manufacturing decisions

Regional dynamics reveal distinct adoption drivers, regulatory landscapes, and supply chain patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each shaping strategic priorities for manufacturers and providers. In the Americas, clinician-driven innovation and high rates of minimally invasive procedures favor advanced suture designs, while centralized procurement in large health systems raises the importance of demonstrated outcomes and cost-effectiveness. This environment prioritizes robust clinical evidence and alignment with hospital efficiency initiatives.

Within Europe, Middle East & Africa, regulatory harmonization efforts and diverse market maturity levels create both opportunities and complexity. Western European markets often demand extensive clinical validation and comprehensive quality documentation, whereas some regions in the Middle East & Africa present opportunities for faster adoption where procedural volumes are increasing and local partnerships can accelerate distribution. Regulatory pathways in these regions require strategic planning to ensure timely access.

Asia-Pacific demonstrates a heterogeneous landscape driven by rapid surgical volume growth, expanding ambulatory care, and an acceleration of local manufacturing capabilities. Policies encouraging domestic production, combined with price sensitivity in several markets, push manufacturers toward flexible pricing, localized manufacturing partnerships, and tailored evidence development. Across all regions, the interplay of clinical practice patterns, regulatory requirements, and procurement norms determines the timing and scale of product adoption.

Key insights on competitive dynamics and strategic partnerships that determine how manufacturers, innovators, and contract partners capture surgeon preference and procurement contracts

Competitive dynamics in the self-locking barbed suture category are shaped by a mix of established multinational device manufacturers, specialized suturing companies, niche innovators, and contract manufacturing partners, each contributing different capabilities to the ecosystem. Leading-scale manufacturers typically leverage broad surgical portfolios, regulatory experience, and global distribution networks to introduce incremental innovations at scale and to bundle training and service programs that support surgeon adoption. Specialized suturing companies often differentiate through focused material science expertise, proprietary barb geometries, or targeted clinical evidence for specific procedures.

Smaller innovators and startups tend to accelerate technology experimentation and rapid iteration, focusing on user feedback and acute clinical pain points. Contract manufacturers play a critical role by enabling scale-up flexibility, cost control, and regional production without necessitating large upfront capital investment from product owners. Across the competitive set, collaboration models such as co-development agreements, OEM supply partnerships, and distribution alliances are increasingly common as companies seek to combine product innovation with market reach.

Intellectual property, clinical data packages, and service models such as surgeon training and procedural support continue to be primary differentiators. Firms that invest in comprehensive post-market surveillance and comparative evidence generation are better positioned to sustain premium positioning and to influence procurement decisions where clinical outcomes drive purchasing behavior.

Practical strategic actions that combine evidence generation, surgeon engagement, supply chain resilience, and channel optimization to accelerate adoption and reduce commercial risk

Industry leaders can take several actionable steps to strengthen position and drive adoption of self-locking barbed sutures while mitigating risk across supply chains and reimbursement environments. First, prioritize targeted evidence generation that aligns with high-volume procedures and stakeholder priorities; comparative studies and real-world evidence that demonstrate reduced procedure time, improved wound integrity, or downstream cost benefits will resonate with clinicians and procurement teams. Second, invest in surgeon training and onboarding programs that reduce friction during early deployment and convert initial exposure into sustained usage through simulation, proctoring, and digital learning modules.

Third, diversify supplier networks and evaluate nearshoring or dual-sourcing strategies to enhance supply continuity and reduce exposure to tariff or logistics shocks. Fourth, tailor go-to-market approaches by channel: direct tender negotiations should emphasize total cost of ownership and bundled services for hospitals, while distributors and online channels can support broader availability for ambulatory and specialty clinic segments. Fifth, consider product line segmentation by material and configuration to match specific procedural needs and to enable premium positioning for specialized indications.

Finally, create cross-functional commercialization teams that integrate clinical affairs, regulatory, supply chain, and commercial leadership to accelerate market access and to respond to regional regulatory variations efficiently. These coordinated efforts will improve time-to-adoption and secure long-term relationships with high-value accounts.

A rigorous mixed-methods research approach combining clinician engagement, secondary literature review, and scenario analysis to validate adoption drivers and supply chain responses

The research underpinning this executive summary integrates primary qualitative engagement with surgical opinion leaders, procurement professionals, and distribution executives alongside secondary analysis of clinical literature, regulatory filings, and device labeling. Primary insights were obtained through structured interviews and moderated discussions to capture real-world handling preferences, procedural considerations, and procurement decision criteria. These qualitative inputs were triangulated with secondary sources to validate trends in procedural adoption, regulatory activity, and material science innovation.

Analytical methods included thematic synthesis of interview data to identify common adoption drivers and barriers, comparative analysis of material performance characteristics documented in peer-reviewed literature, and scenario analysis to assess supply chain responses to policy changes. Data validation steps encompassed cross-checks with clinical guidelines and established surgical best practices, as well as internal consistency checks across diverse stakeholder perspectives. Where quantitative data existed in public literature, findings were contextualized to ensure consistency with qualitative observations.

This blended methodology ensures that conclusions are grounded in practitioner experience and corroborated by independent secondary evidence, delivering a holistic perspective useful for strategic planning and operational decision-making.

Concluding synthesis that links clinical benefits, commercialization imperatives, and supply chain resilience to long-term adoption prospects for advanced suturing technologies

In summary, self-locking barbed sutures represent a strategic intersection of material science, procedure-driven demand, and supply chain considerations that together shape product adoption across surgical specialties. The category's appeal stems from clinical benefits such as streamlined closure workflows and consistent tissue approximation, while the competitive landscape is increasingly defined by evidence generation, surgeon training programs, and resilient sourcing strategies. As healthcare systems emphasize efficiency and outcomes, sutures that demonstrate procedural advantages and align to procurement priorities are positioned to achieve sustained clinical uptake.

Manufacturers and stakeholders must balance investments in product innovation with robust commercialization tactics that include targeted clinical data, flexible manufacturing footprints, and tailored channel strategies. Regional market nuances, regulatory requirements, and the evolving nature of surgical practice all contribute to a dynamic environment where agility and evidence-based commercialization determine long-term success. By aligning technical differentiation with operational execution, stakeholders can convert clinical promise into routine clinical practice and measurable operational improvements.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Self-Locking Barbed Sutures Market, by Configuration

  • 8.1. Bidirectional
  • 8.2. Unidirectional

9. Self-Locking Barbed Sutures Market, by Material

  • 9.1. Absorbable
    • 9.1.1. Poliglecaprone
    • 9.1.2. Polydioxanone
    • 9.1.3. Polyglycolic Acid
  • 9.2. Nonabsorbable
    • 9.2.1. Polyethylene Terephthalate
    • 9.2.2. Polypropylene
    • 9.2.3. Stainless Steel

10. Self-Locking Barbed Sutures Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Specialty Clinics

11. Self-Locking Barbed Sutures Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Self-Locking Barbed Sutures Market, by Application

  • 12.1. Cardiothoracic Surgery
  • 12.2. General Surgery
  • 12.3. Gynecological Surgery
  • 12.4. Orthopedic Surgery
  • 12.5. Plastic Surgery
  • 12.6. Urological Surgery

13. Self-Locking Barbed Sutures Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Self-Locking Barbed Sutures Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Self-Locking Barbed Sutures Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Self-Locking Barbed Sutures Market

17. China Self-Locking Barbed Sutures Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AD Surgical
  • 18.6. Assut Europe
  • 18.7. B Braun SE
  • 18.8. CONMED Corporation
  • 18.9. Corza Medical
  • 18.10. DemeTECH Corporation
  • 18.11. Futura Surgicare Private Limited
  • 18.12. Genesis Medtech Group
  • 18.13. Healthium Medtech Ltd
  • 18.14. Johnson & Johnson Services Inc
  • 18.15. Katsan Medical Devices
  • 18.16. Lotus Surgicals Pvt Ltd
  • 18.17. Medtronic PLC
  • 18.18. Peters Surgical
  • 18.19. Samyang Holdings Corporation
  • 18.20. Smith & Nephew PLC
  • 18.21. Sutumed Corp
  • 18.22. Suture Planet
  • 18.23. Teleflex Incorporated
  • 18.24. Unisur Lifecare Pvt Ltd
  • 18.25. Universal Sutures

LIST OF FIGURES

  • FIGURE 1. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SELF-LOCKING BARBED SUTURES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES SELF-LOCKING BARBED SUTURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA SELF-LOCKING BARBED SUTURES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY BIDIRECTIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY BIDIRECTIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY BIDIRECTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY UNIDIRECTIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY UNIDIRECTIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY UNIDIRECTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY POLIGLECAPRONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY POLIGLECAPRONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY POLIGLECAPRONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY POLYDIOXANONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY POLYDIOXANONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY PLASTIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY PLASTIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY PLASTIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY UROLOGICAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY UROLOGICAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY UROLOGICAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS SELF-LOCKING BARBED SUTURES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE SELF-LOCKING BARBED SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST SELF-LOCKING BARBED SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC SELF-LOCKING BARBED SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN SELF-LOCKING BARBED SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. GCC SELF-LOCKING BARBED SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 148. GCC SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. GCC SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 150. GCC SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GCC SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. GCC SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION SELF-LOCKING BARBED SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS SELF-LOCKING BARBED SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. G7 SELF-LOCKING BARBED SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 172. G7 SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 173. G7 SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 174. G7 SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 175. G7 SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. G7 SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. G7 SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. NATO SELF-LOCKING BARBED SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 180. NATO SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 181. NATO SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 182. NATO SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 183. NATO SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. NATO SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. NATO SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL SELF-LOCKING BARBED SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES SELF-LOCKING BARBED SUTURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA SELF-LOCKING BARBED SUTURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA SELF-LOCKING BARBED SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)